Cargando…
Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19
Therapeutic options for coronaviruses remain limited. To address this unmet medical need, we screened 5406 compounds, including United States Food and Drug Administration (FDA)-approved drugs and bioactives, for activity against a South Korean Middle East respiratory syndrome coronavirus (MERS-CoV)...
Autores principales: | Ko, Meehyun, Chang, So Young, Byun, Soo Young, Ianevski, Aleksandr, Choi, Inhee, Pham Hung d’Alexandry d’Orengiani, Anne-Laure, Ravlo, Erlend, Wang, Wei, Bjørås, Magnar, Kainov, Denis E., Shum, David, Min, Ji-Young, Windisch, Marc P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069929/ https://www.ncbi.nlm.nih.gov/pubmed/33918958 http://dx.doi.org/10.3390/v13040651 |
Ejemplares similares
-
Acid phosphatase 2 (ACP2) is required for membrane fusion during influenza virus entry
por: Lee, Jihye, et al.
Publicado: (2017) -
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
por: Jeon, Sangeun, et al.
Publicado: (2020) -
Characterisation of different forms of the accessory gp3 canine coronavirus type I protein identified in cats
por: Pham-Hung d’Alexandry d’Orengiani, Anne-Laure, et al.
Publicado: (2015) -
Psychometric characteristics of the Revised Illness Perception Questionnaire (IPQ-R) in adults with sickle cell disease
por: Oudin Doglioni, Damien, et al.
Publicado: (2021) -
Antiviral Immunoglobulins of Chicken Egg Yolk for Potential Prevention of SARS-CoV-2 Infection
por: Ravlo, Erlend, et al.
Publicado: (2022)